A Safety and Efficacy Trial of Multiple Dosing Regimens of ABT-719 for the Prevention of Acute Kidney Injury in Subjects Undergoing High Risk Surgery

Study Identifier
M13-958
CT.gov Identifier
NCT01897519
EudraCT Identifier
2012-005710-19
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Other
Sign up for trial alerts

Study Details

Medical Condition
  • Heart, Blood & Circulatory - Other
    • Study Drug
  • Placebo
  • ABT-719
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    18+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    \- Patients undergoing high risk major surgery in subjects with cardiovascular disease who are at risk of AKI.
    Exclusion Criteria:
    * Ongoing or recent history of sepsis * Has recent documented acute kidney injury. * Subject is scheduled to have a total or partial nephrectomy.

    Protocol Summary

    This study will evaluate the safety and efficacy of ABT-719 in patients undergoing high risk major surgery.

    Study Locations

    Location
    Status
    Location
    Site Reference ID/Investigator# 96295
    Gainesville, Florida, United States, 32610
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 96778
    Jacksonville, Florida, United States, 32207
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 96301
    Tampa, Florida, United States, 33613
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 96302
    Fort Wayne, Indiana, United States, 46804
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 101961
    Indianapolis, Indiana, United States, 46237
    Status
    Not applicable
    Location
    Site Reference ID/Investigator# 103356
    Boston, Massachusetts, United States, 02115
    Status
    Not applicable
    Showing {first} - {last} of {total} Results